DT
VIR icon

Diversified Trust’s Vir Biotechnology VIR Stock Holding History

Diversified Trust’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$326K Hold
32,038
– – 0.01% 889
2026
Q1 		$287K Buy
32,038
+3,836
+14% +$30.6K 0.01% 861
2025
Q4 		$170K Buy
28,202
+5,523
+24% +$32.9K ﹤0.01% 984
2025
Q3 		$129K Sell
22,679
-203
-0.9% -$1.04K ﹤0.01% 959
2025
Q2 		$115K Buy
+22,882
New +$123K ﹤0.01% 902
2024
Q1 		– Sell
-21,268
Closed -$214K – 935
2023
Q4 		$214K Buy
+21,268
New +$194K 0.01% 768

Other funds holding VIR

YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FG
Foster Group West Des Moines, Iowa $3.76B AUM 21.29% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.95% 1-Year Est. Return
VCM
Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
TWD
True Wealth Design Akron, Ohio $420M AUM 22.7% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.87B AUM 24.64% 1-Year Est. Return

Diversified Trust's VIR Position: Q2 2026 in Review

Diversified Trust held its Vir Biotechnology (VIR) position steady in Q2 2026 at 32,038 shares worth $326K. The position accounts for 0.01% of the portfolio, ranked #889.

Diversified Trust first reported a position in VIR in Q4 2023 and has held it in 6 quarters since. 14 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Diversified Trust held 32,038 shares of Vir Biotechnology worth $326K as of Q2 2026.
  • Diversified Trust left its Vir Biotechnology share count unchanged in Q2 2026.
  • Vir Biotechnology made up 0.01% of Diversified Trust's portfolio in Q2 2026, its #889 holding.
  • Diversified Trust first reported a position in Vir Biotechnology in Q4 2023 and has held it in 6 quarters since.
  • 14 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Diversified Trust's 13F filing for Q2 2026, filed 17 Jul 2026.